The regulatory domain of conventional protein kinase C (PKC) contains two membrane-targeting modules, the C2 domain that is responsible for Ca 2؉ -dependent membrane binding of protein, and the C1 domain composed of two cysteine-rich zinc fingers (C1a and C1b) that bind diacylglycerols and phorbol esters. To understand the individual roles and the interplay of the C1 and C2 domains in the membrane binding and activation of PKC, we functionally expressed isolated C1 and C2 domains of PKC-␣ and measured their vesicle binding and monolayer penetration. Results indicate that the C2 domain of PKC-␣ is responsible for the initial Ca 2؉ -and phosphatidylserine-dependent electrostatic membrane binding of PKC-␣, whereas the C1 domain is involved in subsequent membrane penetration and diacylglycerol binding, which eventually lead to enzyme activation. To determine the roles of individual zinc fingers in the C1 domain, we also mutated hydrophobic residues in the C1a (Trp  58 and 
ences in the regulatory domain, PKCs are generally classified into three groups; conventional PKC (␣, ␤I, ␤II, and ␥ subtypes), novel PKC (␦, ⑀, , and subtypes), and atypical PKC ( and subtypes). The regulatory domain of conventional PKCs is composed of two conserved membrane-targeting modules, C1 and C2 domains, as well as a pseudosubstrate region and variable regions. Conventional PKCs are activated by the Ca 2ϩ -dependent translocation of proteins to the membrane containing phosphatidylserine (PS) and diacylglycerol (DAG). Structural (3) and mutational (4, 5) studies have shown that the C2 domain of conventional PKC is responsible for the Ca 2ϩ -dependent translocation of the protein to membranes. It has also been shown that the C1 domain, which is composed of a tandem repeat of cysteine-rich zinc-finger domains (C1a and C1b), is involved in binding of PKC to DAG and its structural analogs, phorbol esters (6 -8) . However, the temporal and spatial sequences of membrane targeting and activation of PKC have not been fully elucidated. Furthermore, the interplay of the C1 and C2 domains in these complex processes is poorly understood. Finally, the roles of individual zinc finger domains in the DAGdependent membrane binding and activation of PKC are not well defined. To address these questions, we functionally expressed the isolated C1 and C2 domains of PKC-␣ and measured their vesicle binding and monolayer penetration. We also mutated C1a and C1b domain residues of the native PKC-␣ and measured the effects of mutations on vesicle binding, enzyme activity, and monolayer penetration. Results indicate that the C2 domain of PKC-␣ is responsible for its initial Ca 2ϩ -and PS-dependent membrane binding, whereas the C1 domain is involved in subsequent membrane penetration and DAG binding, which eventually lead to enzyme activation. These studies also show that the two C1 domains have distinct roles in membrane binding and activation of PKC-␣.
EXPERIMENTAL PROCEDURES

Materials-1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS), N-dansyl-1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (dansyl-PE), and 1,2-sn-dioleoylglycerol (DOG) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL) and used without further purification. Tritiated POPC was prepared from 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine and [9,10- 3 H]oleic acid (American Radiochemical Co., St. Louis, MO) using rat liver microsomes as described (9, 10) . Phospholipid concentrations were determined by phosphate analysis (11) . Fatty acid-free bovine serum albumin was from Bayer Inc. (Kankakee, IL). [␥- 32 P]ATP (3 Ci/mol) was from Amersham Pharmacia Biotech, and cold ATP was from Sigma. 4-␤- [ 3 H]hydroxyphorbol-12,13-dibutyrate (PDBu) was from American Radiochemical Co. Triton X-100 was obtained from Pierce. Restriction endonucleases and enzymes for molecular biology were obtained from either Roche Molecular Biochemicals or New England Biolabs (Beverly, MA).
Mutagenesis-Baculovirus transfer vectors encoding the cDNA of PKC-␣ with appropriate C1 domain mutations were generated by the overlap extension polymerase chain reaction (PCR) using pVL1392-PKC-␣ plasmid (12) as a template. Briefly, appropriate complementary * This work was supported by National Institutes of Health Grant GM53987. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Dept. of Chemistry (M/C 111), University of Illinois at Chicago, 845 W. Taylor St., Chicago, IL 60607-7061. Tel.: 312-996-4883; Fax: 312-996-2183; E-mail: wcho @uic.edu. 1 The abbreviations used are: PKC, protein kinase C; dansyl, 5-dimethylaminonaphthalene-1-sulfonyl; dansyl-PE, N-dansyl-1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; DAG, 1,2-sn-diacylglycerol; DOG, 1,2-sn-dioleoylglycerol; PCR, polymerase chain reaction; PDBu, 4-␤-hydroxyphorbol-12,13-dibutyrate; PG, phosphatidylglycerol; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol; POPS, 1-palmitoyl-2-oleoyl-snglycero-3-phosphoserine; PS, phosphatidylserine. synthetic oligonucleotides introducing the desired mutation and two other primers at the 5Ј-end of the PKC-␣ gene and around NcoI site inside PKC-␣ gene were used as primers for PCR performed in a DNA thermal cycler (Perkin-Elmer) using Pfu DNA polymerase (Stratagene). The protocol consists of two steps. In the first step, two DNA fragments overlapping at the mutation site were generated and purified on an agarose gel. Then, these two fragments were annealed and extended to generate a part of PKC-␣ gene containing a mutated regulatory domain (residues 1-389), which was further amplified by PCR. The product was subsequently purified on an agarose gel, digested with NcoI, and subcloned into the pVL1392-PKC-␣ plasmid. The pVL1392-PKC-␣ plasmid used for subcloning was first digested with NcoI, dephosphorylated with alkaline phosphatase to prevent self-ligation, and finally purified on an agarose gel. The mutagenesis was verified by DNA sequencing of part of PKC-␣ gene that had been subjected to PCR mutagenesis using a Sequenase 2.0 kit (Amersham Pharmacia Biotech).
Expression vectors for isolated C1 and C2 domains were generated by PCR using the pVL1392-PKC-␣ as a template. For the C1 domain expression vector, a NcoI site was incorporated at the 5Ј-end so that the translation started from Met in position 31 of the PKC-␣ coding sequence. A XhoI site was also introduced after His 155 at the 3Ј-end. The gene for the C1 domain (residues 31-155) was subcloned into the pET21d vector using the NcoI and XhoI sites (Novagen, Madison, WI). This vector is designed to introduce a carboxyl-terminal His 6 tag between the XhoI site and a stop codon for affinity purification of expressed proteins. For the C2 domain expression vector, a new NcoI site was created at the 5Ј-end in order for the translation to start at the Met 153 , and residue 154 was mutated to Ala to ensure the removal of Met 153 by bacterial methionine amino peptidase. A XhoI site was incorporated after residue 284, and the gene for the C2 domain, spanning residues 153-284, was subcloned into pET21d vector. This construct also contains a carboxyl-terminal His 6 tag. All constructs were verified by restriction digestion and DNA sequencing.
Expression of PKC-␣ and Mutants in Baculovirus-infected Sf9
Cells-Wild type PKC-␣ and mutants were expressed in baculovirusinfected Sf9 cells (Invitrogen, La Jolla, CA). Transfection of Sf9 cells with mutant pVL1392-PKC-␣ constructs was performed using a BaculoGold TM transfection kit from Pharmingen (San Diego, CA). Plasmid DNA for transfection was prepared by using an EndoFree Plasmid Maxi kit (Qiagen, Valencia, CA) to avoid potential endotoxin contamination. A detailed protocol for expression and purification of PKC-␣ from Sf9 cells is described elsewhere (12). Protein concentration was determined by the bicinchoninic acid method using bovine serum albumin as standard (Pierce).
Bacterial Expression and Purification of Isolated C1 and C2 Domains of PKC-␣-Escherichia coli strain BL21(DE3) (Novagen) was used as a host for protein expression. One liter of Luria broth supplemented with 100 g/ml ampicillin was inoculated with 1 ml of overnight culture grown at 37°C. Cells were grown at 37°C until their absorbance at 600 nm reached approximately 0.8, and the protein expression was then induced with 0.5 mM isopropyl-1-thio-␤-D-galactopyranoside (Research Products, Mount Prospect, IL). After 4 h, cells were harvested by centrifugation (5000 ϫ g for 10 min at 4°C). For C1 domain purification, cells were resuspended in 20 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 50 mM NaCl, 0.4% (v/v) Triton X-100, 0.4% (w/v) sodium deoxycholate, and 1 mM phenylmethylsulfonyl fluoride. After the suspension was sonicated, the inclusion body pellet was obtained by centrifugation at 100,000 ϫ g for 15 min at 4°C. The pellet was resuspended in 20 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 50 mM NaCl, 0.8% (v/v) Triton X-100, 0.8% (w/v) sodium deoxycholate, and the suspension was sonicated as described above. After centrifugation at 100,000 ϫ g for 15 min at 4°C, the pellet was resuspended in 20 ml of 50 mM Tris-HCl buffer, pH 7.5, and stirred for 15 min at room temperature, and the suspension was centrifuged at 100,000 ϫ g for 10 min at 4°C. The washed inclusion body was resuspended in 20 ml of 50 mM Tris-HCl buffer, pH 7.5, containing 8 M urea and 5 mM dithiothreitol and stirred at room temperature for 1-2 h. Insoluble matter was removed by centrifugation at 100,000 ϫ g for 10 min at 4°C, and the supernatant was dialyzed against 50 mM Tris-HCl, pH 7.5, 1.5 M urea, 50 M ZnCl 2 , and 0.5 mM dithiothreitol and then against 50 mM TrisHCl, pH 7.5. The refolded C1 domain was purified using a Ni-NTA agarose column (Qiagen) according to the manufacturer's instructions. For isolated C2 domain purification, harvested cells were resuspended in 50 mM KH 2 PO 4 buffer, pH 7.5, 300 mM NaCl, and 10 mM imidazole, and the suspension was sonicated. The supernatant was collected by centrifugation at 50,000 ϫ g for 45 min at 4°C. The C2 domain was purified using a Ni-NTA agarose column according to the manufacturer's instructions. Purity of protein samples was judged to be higher than 90% using SDS electrophoresis gels. Aliquots of purified proteins were stored at Ϫ20°C.
Determination of PKC Activity-The activity of PKC was assayed by measuring the initial rate of [ 32 P]phosphate incorporation from [␥-32 P]ATP (50 M, 0.6 Ci/tube) into the histone III-SS (400 g/ml) (Sigma). The reaction mixture contained large unilamellar vesicles (0.1 mM), 5 mM MgCl 2 , 12 nM PKC, and 100 M CaCl 2 in 50 l of 20 mM HEPES, pH 7.0. Protamine sulfate (200 g/ml) was used to assess the free enzyme concentration in vesicle binding measurements (see below). Free calcium concentration was adjusted using a mixture of EGTA and CaCl 2 according to the method of Bers (13) . Reactions were started by adding the MgCl 2 to the mixture and quenched by adding 50 l of 1% aqueous phosphoric acid solution after a given period of incubation (e.g. 5 min for histone) at room temperature. Seventy-five microliters of quenched reaction mixtures was spotted on P-81 ion-exchange papers (Whatman), and papers were washed four times with 1% aqueous phosphoric acid solution and washed once with 95% aqueous ethanol. Papers were then transferred into scintillation vials containing 4 ml of scintillation fluid (Sigma), and radioactivity was measured by liquid scintillation counting. The linearity of the time dependence of the reaction was checked by monitoring the degree of phosphorylation at regular intervals.
Vesicle Binding Measurements-The binding of PKC to phospholipid vesicles was measured by a centrifugation assay using large sucroseloaded unilamellar vesicles (100 nm in diameter) (14) . Sucrose-loaded vesicles were prepared as described elsewhere (4 The binding of isolated C1 and C2 domains to phospholipid vesicles was measured by the same centrifugation assay. For these measurements, binding assay mixtures containing 0.6 M protein in 500 l of 10 mM HEPES buffer, pH 7.0, containing 0.1 M KCl, 0.1 mM Ca 2ϩ (or 0.5 mM EGTA), and 0.5 mM phospholipid were incubated for 15 min at room temperature and centrifuged at 100,000 ϫ g for 30 min at 25°C. Supernatants were decanted, and pellets were resuspended in 15 l of 10 mM HEPES buffer, pH 7.0, containing 0.1 M KCl and 0.5 mM EGTA. Resuspended pellets were loaded on 14% polyacrylamide gels and proteins were separated by SDS-polyacrylamide gel electrophoresis. The amount of protein in each band was quantified using an IS-1000 digital imaging system (Key Scientific, Mt. Prospect, IL). To convert the protein band density to the protein concentration, a standard curve was constructed from density values of varying amounts of C1 and C2 domain samples (1-5 g domain of PKC-␣ to vesicles was also measured by fluorescence resonance energy transfer from tryptophans in the protein to a dansyl group of dansyl-PE as a function of increasing Ca 2ϩ concentration. Large unilamellar vesicles with 10 mol % of dansyl-PE were prepared by multiple extrusion through a 0.1-m polycarbonate filter. The fluorescence measurements were performed in a Hitachi F4500 fluorescence spectrometer with the excitation and emission wavelength set at 281 and 511 nm, respectively. First, lipid vesicles containing 10% dansyl-PE were added to 2.0 ml of 10 mM HEPES buffer, pH 7.0, containing 0.1 M KCl and 0.5 M C2 domain, and the initial fluorescence intensity was recorded. Then, the solution was titrated with Ca 2ϩ . Increase in fluorescence (⌬I) after each addition of Ca 2ϩ was measured, and the relative fluorescence increase (⌬I/⌬I max ), where ⌬I max is a maximal fluorescence change, was plotted as a function of Ca 2ϩ concentration. 
where y, a, h, and [Ca 2ϩ ] are relative binding, arbitrary normalization constant, Hill coefficient, and free Ca 2ϩ concentration, respectively. Monolayer Measurements-Surface pressure () of solution in a circular Teflon trough was measured using a du Nouy ring attached to a computer-controlled Cahn electrobalance (Model C-32) as described previously (12, 17). The trough (4 cm in diameter ϫ 1 cm deep) has a 0.5-cm-deep well for a magnetic stir bar and a small hole drilled at an angle through the wall to allow addition of protein solution. Five to 10 l of phospholipid solution in ethanol/hexane (1:9 (v/v)) or chloroform was spread onto 10 ml of subphase (20 mM HEPES, pH 7.0 containing either 0.1 or 0.5 mM of free Ca 2ϩ ) to form a monolayer with a given initial surface pressure ( o ). The subphase was continuously stirred at 60 rpm with a magnetic stir bar. Once the surface pressure reading of monolayer had been stabilized (after approximately 5 min), the protein solution (typically 50 l) was injected into the subphase, and the change in surface pressure (⌬) was measured as a function of time at 23°C. Typically, the ⌬ value reached a maximum after 20 min. The maximal ⌬ value depended on the protein concentration and reached a saturation when the protein concentration was above a certain value. Protein concentrations in the subphase were therefore maintained above such values to ensure that the observed ⌬ represented a maximal value. The critical surface pressure ( c ) was determined by extrapolating the ⌬ versus o plot to the x axis.
RESULTS
Vesicle and Monolayer Binding of Isolated C1 and C2 Domains-To determine the roles of the C1 and C2 domains in Ca 2ϩ -, PS-, and DAG-dependent membrane binding and activation of PKC-␣, we expressed the isolated C1 domain (residues 32-155) and the isolated C2 domain (residues 154 -284) and measured their properties. The isolated C1 domain containing both C1a and C1b domains was expressed in E. coli as an inclusion body, which was dissolved in an 8 M urea solution and refolded. On the other hand, the C2 domain was expressed mainly as a soluble protein. Because both proteins contain a carboxyl-terminal His 6 tag, they were readily purified by affinity chromatography to near homogeneity. Protein yields after purification were typically 5-10 mg/liter of medium. Although we did not determine the tertiary structures of these isolated domains, they appear to be correctly folded based on their vesicle binding and monolayer penetration behaviors that are consistent with their putative functions (see below).
We first measured the PDBu binding of the wild type PKC-␣ and the isolated C1 domain to test if the C1 domain is correctly folded. Fig. 1 shows that the two proteins have similar binding isotherms. The stoichiometry (n) and the dissociation constant (K d ) of the PKC-PDBu complex were determined using the equation Table I . As indicated by these parameters, the C1 domain did not distinguish PS and PG regardless of the presence of 1 mol % DOG in mixed vesicles, indicating the lack of specific PS-binding sites in this domain. The binding was also independent of Ca 2ϩ in solution (data not shown).
We also measured the binding of the isolated C2 domain to mixed vesicles with different compositions. Membrane binding properties of isolated C2 domains of cytosolic phospholipase A 2 (16, 19 -21) and synaptotagmin (22) have been extensively characterized. However, properties of an isolated C2 domain of conventional PKCs have not been measured. We first determined the Ca 2ϩ dependence of binding of the C2 domain to vesicles containing either PG or PS by the fluorescence resonance energy transfer from tryptophans of the C2 domain to dansyl-PE in vesicles. The presence of four tryptophans in the C2 domain allowed for sensitive measurement of this Ca 2ϩ -dependent binding. As shown in Fig. 3 , Ca 2ϩ was essential for the vesicle binding of the C2 domain, but DOG had no effect on binding. In contrast to the C1 domain, which showed no PS selectivity, the C2 domain demonstrated significant PS preference. Over the wide Ca 2ϩ concentration range, the C2 domain bound more tightly to POPC/POPS/dansyl-PE (7:2:1) vesicles than to POPC/POPG/dansyl-PE (7:2:1) vesicles. Because dansyl-PE was shown to promote the membrane binding and activation of conventional PKCs as well as PS (23), a larger separation of the two curves would be expected if the binding was measured in the absence of dansyl-PE by, e.g. the centrifugation method. As listed in Table I , [Ca 2ϩ ] 1/2 values were 10 M for PS-containing vesicles and 60 M for PG-containing vesicles. To compare this PS selectivity with that of the native PKC-␣, we measured the Ca 2ϩ dependence of binding of PKC-␣ to the same vesicles (Fig. 4) . As reported previously (12), PS selectivity of PKC-␣ was more pronounced in the presence of DOG in the vesicles. Importantly, the PS selectivity of the isolated C2 domain, as indicated by, e.g. the ratio of [Ca 2ϩ ] 1/2 values for PS and PG-containing vesicles, is only modestly higher than that of the native PKC-␣ measured in the absence of DAG under the same conditions (see Table I ). This indicates that the intrinsic (i.e. DAG-independent) PS selectivity of PKC-␣ stems from the C2 domain. We also measured the PS and PG dependence of C2 domain vesicle binding (Fig. 5) . In this case, we used the centrifugation method to avoid the use of dansyl-PE, which would complicate the interpretation of PS and PG dependence. Again, PS preference of the C2 domain was manifest, and DOG had no effect. As shown in Table II , half-maximal vesicle binding was achieved with 15 mol % of PS and 30 mol % of PG.
We then measured the monolayer penetration of the isolated C1 and C2 domains. Our recent study showed that PS specifically induces the Ca 2ϩ -dependent membrane penetration of PKC-␣ whereas other anionic phospholipids such as PG cannot (12). Lipid monolayers have proven to be a sensitive tool for measuring lipid-protein interactions (24, 25) , including PKCmembrane interactions (12, 26, 27) . In these studies, a phospholipid monolayer of a given initial surface pressure o was spread at constant area, and the change in surface pressure (⌬) was monitored after the injection of the protein into the subphase. Those proteins the actions of which involve the partial or full penetration of membranes have an ability to penetrate into the phospholipid monolayer with o comparable to or higher than that of biological membranes (approximately 31 dyne/cm) (28 -31), and vice versa. The ⌬ versus o plots for PKC-␣, C1 and C2 domains are shown in Fig. 6 , and c values, determined by extrapolating the plots to the x axis, are summarized in Table I . As reported previously, PKC-␣ could penetrate into the POPC/POPS (7:3) monolayer in a Ca 2ϩ -dependent manner even when o Ͼ 35 dyne/cm, demonstrating its ability to penetrate into biological membranes (12). Toward this monolayer, the isolated C1 domain showed much higher penetrating power ( c ϭ 41 dyne/cm) than did PKC-␣ ( c ϭ 37 dyne/cm) and the isolated C2 domain ( c ϭ 28 dyne/cm). This indicates that the C1 domain is involved in membrane penetration in the course of membrane binding of PKC-␣. Unlike the native PKC-␣, the monolayer penetration of which depends on the presence of Ca 2ϩ in the subphase and PS in the monolayer (12), the isolated C1 domain exhibited high penetrating power regardless of the nature of anionic phospholipids in the monolayer and also in the absence of Ca 2ϩ in the subphase. The penetration of the isolated C1 domain, however, required the presence of anionic phospholipid in the monolayer, as it showed much lower penetration into the pure POPC monolayer (data not shown). As is the case with the native PKC-␣ (12), DOG in the monolayer did not affect the monolayer penetration of the C1 domain (data not shown). When compared with the C1 domain, the C2 domain in general showed a lower penetration power but had a significant degree of PS preference. Also, the monolayer penetration of the C2 domain was dependent upon Ca 2ϩ in the subphase. These results indicate that the C1 do- main of PKC-␣ is primarily responsible for its membrane penetration, whereas the C2 domain is involved in Ca 2ϩ -dependent PS-specific membrane binding and partial membrane penetration.
Vesicle Binding and Monolayer Penetration of C1 Domain Mutants-An x-ray crystallographic study of a single zinc finger domain (C1b) of PKC-␦ has shown that this 50-amino acid region adopts a globular, compact ␣/␤ fold with two Zn 2ϩ atoms as an integral part of the structure (32) (Fig. 7A) . This zinc finger domain has an uneven distribution of hydrophobic and polar residues. The upper part of molecule, where the DAG/ phorbol ester binding pocket is located, contains a few hydrophobic residues, whereas the middle part includes a number of cationic residues. Based on this structure and the NMR structure of micelle-bound C1b domain of PKC-␣ (33), it has been proposed that the upper part of this domain is inserted into membranes in the course of membrane binding of PKC, whereas the cationic residues in the middle make contact with phospholipid head groups (32) . Our monolayer penetration data indeed demonstrate that the C1 domain has high membrane penetration power. Because only one DAG/phorbol ester molecule is required for activating a conventional PKC molecule (15, 34 -36) , the roles of the two C1 domains in the membrane binding and activation of conventional PKC remain unclear. High sequence homology between C1a and C1b domains (see Fig. 7B ) predicts that the two domains would have similar tertiary structures. To determine the roles of individual zinc finger domains in the membrane binding and activation of PKC-␣, we mutated prominent hydrophobic residues in the putative membrane-penetrating regions of the two C1 domains: i.e. Table II . Evidently, mutations of C1a domain hydrophobic residues (W58G and F60G) had much more pronounced effects on the vesicle binding than did those of C1b domain hydrophobic residues (Y123G and L125G). W58G and F60G required significantly higher DOG concentrations for vesicle binding than did the wild type, whereas Y123G and L125G mutants behaved essentially the same as the wild type did. This suggests that the C1a domain might play a more important role than C1b in the DAG-dependent vesicle binding of PKC-␣. To see whether reduced DAG binding affinity of the C1a domain mutants is directly translated into lower enzyme activity, we then measured the PKC activity of wild type and mutants as a function of DOG content. When the kinase activity of wild type and mutants toward histone was measured in the presence of the same vesicles used for binding measurements, C1a domain mutations exhibited much larger effects than did C1b domain mutations (Fig. 9) . In this case, the differential effects were more pronounced. Again, Y123G and L125G behaved similarly to wild type PKC-␣. However, F60G and W58G showed only 40 and 10% of the wild type activity, respectively, with 5 mol % DOG, which allowed full and 70% vesicle binding of F60G and W58G, respectively (see Fig. 8 ).
We then measured the PS dependence of the binding of wild type and mutants to POPC/POPS vesicles containing 1 mol % of DOG in the presence of 0.1 mM Ca 2ϩ . The PS dependence is shown in Fig. 10 however, all mutants, including W58G, were fully bound to vesicles containing 1 mol % DOG. This suggests that reduced DAG affinity of C1a domain mutants can be compensated for by higher PS concentrations, which is also consistent with our previous finding that PKC-␣ can be fully vesicle-bound without DAG in the presence of high PS content in vesicles (12). We also measured the PS dependence of the enzyme activity of wild type and mutants (Fig. 11) . Note that under the conditions where all protein molecules are vesicle-bound (i.e. [PS] Ͼ 40 mol %), F60G and W58G showed only 60 and 10% of the wild type activity, respectively (see also Taken together, these results suggest that hydrophobic interactions between C1a domain and membranes are essential for the DAG binding and activation of PKC-␣. In contrast, the C1b domain is not directly involved in these processes.
Finally, we measured the interaction of PKC-␣ and C1 domain mutants with phospholipid monolayers to test the notion that a part of the C1a domain, but not that of C1b domain, penetrates into membranes in the course of its membrane binding. As shown in Fig. 12 , the penetrating power of was greatly reduced compared to wild type PKC-␣, and its c value is 30 dyne/cm, suggesting that it could not penetrate into biological membranes. In contrast, C1b domain mutants, Y123G and L125G, showed essentially the same monolayer penetration as wild type. These results thus strongly support the notion that the C1a domain of PKC-␣ is primarily responsible for membrane penetration, DAG binding, and enzyme activation.
DISCUSSION
The membrane translocation and activation of conventional PKC requires Ca 2ϩ , PS, and DAG under physiological conditions. Conventional PKCs have two membrane-targeting modules, the C1 and C2 domains, which are responsible for its membrane binding and activation. A consensus mechanism of in vitro PKC activation is that the C1 and C2 domains work in concert to bring the PKC molecule to the membrane surface, where the protein undergoes conformational changes to remove the pseudosubstrate region from the active site, resulting in PKC activation (1, 37) . Extensive structural and mutation studies have helped understand the roles of individual domains in the membrane targeting and activation of PKCs and identify those amino acids that are critically involved in these processes. For instance, our structure-function study of the C2 domain of PKC-␣ defined the role of C2 domain as a membrane docking unit as well as a module that triggers conformational changes of protein for its activation (4) . Also, extensive mutagenesis studies on the C1b domain of PKC-␦ identified the essential amino acids for phorbol ester binding (38, 39) . Less is known, however, about the temporal and spatial sequences of membrane targeting and activation of PKCs. A recent elegant cell study indicated that the activation of PKC-␥ follows well defined sequential steps in which the Ca 2ϩ -dependent membrane binding of the C2 domain is followed by the DG/phorbol ester binding of the C1 domain (40) . This report describes systematic structure-function studies of the two domains of PKC-␣ that provide first detailed insights into the temporal and spatial sequences of in vitro membrane targeting and activation of PKC-␣.
Differential Roles of C1 and C2 Domains in Membrane Binding of PKC-␣-For most peripheral membrane binding proteins, both electrostatic and hydrophobic interactions play roles in their membrane binding, although their relative contributions vary with the type of proteins (17, 41, 42) . We have shown that the membrane binding of PKC-␣ is also driven by these interactions; electrostatic interactions of the protein-bound calcium ions and other cationic residues of PKC-␣ with anionic phospholipids and hydrophobic interactions resulting from the Ca 2ϩ -and PS-dependent penetration of PKC into the hydrophobic core of the membrane (4, 12). Thus, Ca 2ϩ and PS are involved not only in direct electrostatic interaction but also in eliciting hydrophobic interactions. Extensive in vitro studies have shown that the activation of conventional PKC requires the binding of multiple PS molecules (43) and a single DAG (or phorbol ester) molecule to PKC (34) . Also, the PS specificity of conventional PKC is much more pronounced in the presence of DAG in the membrane, suggesting the synergism between PS- 6 . Effect of the initial surface pressure of monolayers on the penetration of PKC-␣ (E) and isolated C1 (Ⅺ and f) and C2 domains (‚ and OE). Monolayers contained either POPC/POPS (7:3) (open symbols) or POPC:POPG (7:3) mixed monolayers (filled symbols). The protein concentration in the subphase was 1.5 g/ml for PKC-␣ and 4 g/ml for C1 and C2 domains. The subphase contained 20 mM HEPES buffer, pH 7.0, with 0.1 mM free Ca 2ϩ . The penetration of C1 (q) and C2 () domains into POPC:POPS (7:3) was also measured in the presence of 0.1 mM EGTA. binding site(s) and a DAG-binding site (44) . Structural (32) and mutation analyses (38, 39) have clearly identified the DAGbinding site in each of two C1 domains, although it is unclear which of the two binding sites is actually involved in binding to a single DAG molecule. The presence and location of PS-specific binding site(s) remains controversial, however, because some synthetic phospholipids, such as dansyl-PE, are also able to simulate the effects of PS (23) .
Our studies indicate that the C2 domain of PKC-␣ has significant PS selectivity, whereas the C1 domain shows essentially no selectivity. Both the Ca 2ϩ dependence (Fig. 3) and the anionic lipid content dependence (Fig. 5 ) of vesicle binding demonstrate that the isolated C2 domain prefers PS to PG. It should be noted that the observed PS selectivity of the isolated C2 domain is comparable to that of the native PKC-␣ measured in the absence of DAG under the same conditions (Fig. 4) . Taking into account that the pronounced PS specificity of PKC-␣ results from the synergism between PS-and DAGbinding sites, these findings provide strong evidence that the C2 domain is largely responsible for the intrinsic PS-selectivity of PKC-␣. This also points to the presence of PS-binding sites in the C2 domain. We previously showed that some residues in the C2 domain of PKC-␣ are involved in Ca 2ϩ -and PS-dependent partial membrane penetration (4). The monolayer penetration properties of the isolated C2 domain corroborate this notion. When compared with the C1 domain, however, the C2 domain would play only a minor role in membrane penetration and hydrophobic interactions. In conjunction with our previous study on the C2 domain of PKC-␣ (4), these studies thus show that the C2 domain is mainly responsible for its Ca 2ϩ -and PS-dependent electrostatic binding to membranes.
These studies also show that the C1 domain of PKC-␣ plays a central role in membrane penetration and resulting hydrophobic interactions. This notion is consistent with the DAG binding capacity of the C1 domain. Because DAG lacks a large polar head group, it would be slightly buried from the polar surface of phospholipid membranes, and as a result, it might not be readily accessible to PKC unless the C1 domain with a DAG-binding site penetrates into membranes. The isolated C1 domain demonstrates exceptional monolayer penetration power that far exceeds that of the native PKC-␣. This suggests that the membrane penetrating power of the C1 domain in the PKC-␣ molecule is actually restrained by other parts of the molecule. The high affinity of the isolated C1 domain for PDBu (see Fig. 1 ) shows that it is functionally folded, thereby ruling out the possibility that high monolayer penetration power of the isolated C1 domain is due to the incomplete folding of the domain. The vesicle binding and monolayer penetration of the isolated C1 domain is independent of Ca 2ϩ and PS. Thus, unlike the case of native PKC-␣, the membrane penetration of the isolated C1 domain is not triggered by the specific PS binding and concomitant conformational changes (12), but takes place spontaneously due to a propensity of the C1 domain to penetrate into the membrane. Both the vesicle binding and the monolayer penetration of the C1 domain require, however, the presence of anionic phospholipids, indicating that nonspecific electrostatic interactions are a driving force for its initial membrane binding. A recent monolayer study has shown that the monolayer penetration of surface active proteins, such as apolipoproteins, follows a two-step mechanism in which electrostatic surface adsorption precedes the insertion of hydrophobic side chains into the hydrophobic moiety of the monolayer (45) . Based on the tertiary structure and monolayer penetration properties of the isolated C1 domain, it appears that the membrane penetration of the C1 domain follows a similar mechanism. For the isolated C1 domain, nonspecific electrostatic interactions between anionic phospholipids and the cationic cluster in the middle of the C1 domain (see Fig. 7A ) would bring the domain to the membrane surface and then the hydrophobic tip of the domain would penetrate into the hydrophobic core of the membrane to bind DAG. For the whole PKC-␣ molecule, the C2 domain would primarily play the role of bringing the C1 domain to the membrane surface. The contribution of C1 domain cationic residues to the initial electrostatic membrane interactions of PKC-␣ remains to be assessed. As is the case with the native PKC-␣ (12), DAG does not enhance the penetration of the C1 domain, although it greatly increases the vesicle binding affinity. This indicates that the DAG binding is the consequence but not the driving force of the . Each data point is from a single measurement. The penetration of W60G was not measured due to difficulty in obtaining sufficient amounts of purified protein.
membrane penetration of the domain. In this regard, it is noteworthy that DAG has been shown to induce local PS-rich membrane domains (46) . The preferential binding of conventional PKCs to such domains would trigger the membrane penetration and DAG binding. Thus, DAG might indirectly promote the membrane penetration of conventional PKCs via the PS domain formation. Taken together, these studies show that the C1 domain is primarily involved in the membrane penetration of PKC-␣, which is essential for its DAG binding, hydrophobic membrane interactions, and activation.
Differential Roles of C1a and C1b Domains-One-to-one stoichiometry of conventional PKC-DAG (or phorbol ester) binding indicates that only one of two DAG-binding sites is actually involved in the DAG binding and PKC activation. A recent binding study using a fluorescent phorbol ester analog suggested that PKC-␣ has two discrete phorbol ester-binding sites with different affinity (47) . It was also found that DAG and phorbol esters bind to the two discrete sites with opposite affinity, so that a high affinity DAG-binding site is a low affinity phorbol ester-binding site and vice versa (48) . Our structure-function analyses of the two zinc finger domains show that the C1a domain contains the high affinity DAGbinding site. We designed our mutations based on the premise that the removal of hydrophobic residues from the tip of each zinc finger domain that contains the DAG binding pocket would greatly reduce its ability to penetrate into the hydrophobic core of the membrane, thereby lowering DAG affinity. The effects of mutations on the monolayer penetration of PKC-␣ indicate that the upper part of the C1a domain penetrates into the membrane, whereas its counterpart in the C1b domain does not. Thus, only the C1a domain would be allowed to interact with DAG. These studies do not provide the quantitative information about the degree of membrane penetration by C1a domain. A large decrease in monolayer penetration by a single W58G mutation suggests that this residue might fully penetrate into the hydrophobic core of the membrane. Vesicle binding affinity and enzyme activity of the two groups of mutants corroborate the differential membrane penetration of the two C1 domains. C1a domain mutants (W58G and F60G) have much lower vesicle binding affinity and enzyme activity than does the wild type PKC-␣, whereas corresponding C1b domain mutants (Y123G and L125G) behave essentially the same as the wild type does. Both W58G and F60G show much larger decreases in activity than expected from their reduced membrane affinity. In particular, W58G show only 10% of the wild type activity even when it is driven to fully bind to vesicles by electrostatic interactions (e.g. with high PS concentrations in vesicles; see Fig. 11 ). This indicates that the membrane insertion of the C1a domain is absolutely necessary for PKC activity. However, our results could not rule out a possibility that C1b domain might also be able to interact with DAG without penetrating into the membrane. It has been generally proposed that the activation of conventional PKC results from the removal of the pseudosubstrate region from the active site of PKC (49) . The C1a domain is immediately linked to the pseudosubstrate region, and thus conformational changes accompanying the penetration of C1a domain into the membrane might provide a mechanical force to remove the pseudosubstrate region from the active site.
The origin of the different membrane penetrating power of the two zinc finger domains is still unclear. Based on the domain structure of conventional PKC, however, one can speculate that the difference derives from a mechanical reason. As described above, the C1 domain in the intact PKC molecule cannot fully express its intrinsic membrane penetration power, presumably because other parts of the molecule interfere with the penetration. The C1a domain is flanked by the aminoterminal pseudosubstrate region and the C1b domain, whereas the C1b domain is immediately linked to the C1a domain and the C2 domain (see Fig. 13 ). Thus, it is reasonable to assume that the movement of the C1a domain, which is preceded only by a short and putatively flexible amino-terminal region, might be energetically more favorable than that of C1b domain, which might entail a gross conformational change. It is also possible that the C1b domain is involved in stabilizing interactions with the C2 domain, which must be disrupted for the penetration of C1a domain to take place. Indeed, a recent study suggested that the C1b domain of PKC-␤ provides several ligands for Ca 2ϩ sites in the C2 domain (3). Although our data indicate that a large difference in DAG affinity between the two C1 domains derives mainly from the difference in their membrane localization, one cannot rule out the possibility that the two zinc finger domains actually have different intrinsic DAG/phorbol ester affinities. Conflicting results have been reported with respect to the relative DAG/ phorbol ester affinity of the two zinc fingers in the C1 domain. On one hand, a cell study using isolated C1a and C1b domains of PKC-␥ tagged with green fluorescence protein indicated that the C1a domain is mainly responsible for DAG/phorbol esters binding (50) . On the other hand, mutations of a conserved proline in each C1 domain of PKC-␦ showed that C1b is responsible for phorbol ester-induced membrane translocation in vivo (51) . Thus, depending on the PKC isoform and the nature of C1 domain ligand, relative affinity of C1a and C1b domains might vary to large degrees (52) . In any event, our results underscore that relative affinity of the two C1 domains for a particular ligand depends not only on their intrinsic binding affinity but also on the spatial arrangement of the binding site and the ligand in the membrane. The relationship between the relative affinity of the two C1 domains of PKC-␣ for various phorbol esters and different membrane localization of these ligands is under investigation. 
Proposed Mechanism of in Vitro Membrane Binding and
Activation of PKC-␣-Based on our previous and present studies, we propose the following mechanism for the in vitro membrane binding and activation of conventional PKC (Fig. 13) . The protein initially binds to the membrane surface via the Ca 2ϩ -dependent PS binding of the C2 domain. Once bound to PS-containing membranes, the protein undergoes conformational changes that include the insertion of C1a domain into the membrane. This membrane penetration allows for optimal DAG binding and drives the release of pseudosubstrate region from the active site. The former results in enhanced hydrophobic interactions and overall membrane affinity, and the latter leads to PKC activation. The proposed temporal and spatial sequences are further supported by the following observations. First, dominant negative mutants of the C2 domain of PKC-␣ (e.g. D246N) containing the intact C1 domain can neither bind to nor penetrate into membranes even in the presence of DAG (4) . This indicates that the C2 domain must first bind to the membrane prior to the membrane penetration of the C1 domain. Second, in the absence of DAG in the membrane, Ca 2ϩ -and PS-dependent membrane binding properties of isolated C2 domain and dominant C1 domain mutants (e.g. W58G) are essentially the same as the native PKC. This again indicates that the C2 domain alone can bring the PKC molecule to the membrane surface. Third, membrane binding properties of the isolated C1 domain are distinct from those of the native PKC-␣ under all conditions employed, suggesting that the membrane binding of C1 domain might have to be primed by the membrane binding of C2 domain.
Our proposed mechanism can successfully account for the in vitro Ca 2ϩ , PS-and DAG-dependent membrane binding, and activation of conventional PKC. However, the mechanism of phorbol ester-induced activation of PKC might be different from this mechanism (53, 54) . Also, other factors, most notably PKC phosphorylation (55) and PKC adapter proteins (56) , must be taken into account to understand the in vivo membrane targeting and activation of PKC. The fact that our proposed mechanism is consistent with one proposed by Oancea and Meyer (40) based on their cell studies using fluorescencetagged PKC-␥ suggests that in vivo and in vitro activation of PKC follows essentially the same mechanism. The proposed mechanism provides a conceptual framework to quantitatively determine the forces involved in individual steps, to identify the PKC residues essential for each step, and finally to test whether or not other groups of PKC, novel and atypical PKCs, are targeted to membranes and activated by the same mechanism.
